NCT00745069View on ClinicalTrials.gov

Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

670

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

August 31, 2005

Conditions

OsteoarthitisChronic PainKnee Pain

Interventions

DRUG

tapentadol HCl

Sponsors

Collaborators (1)

Grünenthal GmbH

All Listed Sponsors

collaborator

Grünenthal GmbH

INDUSTRY

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY